SOM0226 ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
28	Systemic amyloidosis	2

28. Systemic amyloidosis

Clinical trials : 267 / Drugs : 241 - (DrugBank : 77) / Drug target genes : 68 - Drug target pathways : 180

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2014-001586-27-ES (EUCTR)	25/07/2014	02/06/2014	Study of SOM0226in familial amyloid polyneuropathy (FAP) patients and asymptomatic carriers to evalu ...	Study of SOM0226in familial amyloid polyneuropathy (FAP) patients and asymptomatic carriers to evalu ...	Patients with familial amyloid polyneuropathy (FAP), asymptomatic carriers and healthy volunteers Me ...	Trade Name: Tasmar INN or Proposed INN: TOLCAPONE	SOM Innovation Biotech SL (SOM Biotech)	NULL	Not Recruiting			Female: yes Male: yes			Spain
2	NCT02191826 (ClinicalTrials.gov)	July 2014	9/7/2014	Study of SOM0226 in Familial Amyloid Polyneuropathy	Study of SOM0226in Familial Amyloid Polyneuropathy (FAP) Patients and Asymptomatic Carriers to Evalu ...	Familial Amyloid Polyneuropathy (FAP)	Drug: SOM0226	SOM Biotech SL	Hospital Vall d'Hebron	Completed	18 Years	N/A	Both	17	Phase 1/Phase 2	Spain

First Previous1Next Last